Evolent Health Cash Flow - Annual (NYSE:EVH)

Add to My Stocks
$23.7 $0.3 (1.25%) EVH stock closing price Aug 17, 2018 (Closing)

The financial analysis of EVH requires an investor to check the cash flows for Evolent Health. While its important to look at the Evolent Health debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Evolent Health revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. Evolent Health had cash and cash equivalents of $170.02M at beginning of the year and $295.36M at year end for 2017. Evolent Health cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. Evolent Health had an outflow of $-27.95M from operating activities, $165.55M inflow due to financing activities, and $-12.26M outflow due to investing activities for 2017.

View details of Evolent Health cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec20172016201520142013
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow33.28M177.82M7.16M3.69M1.83M
Net Increase (Decrease) in Assets Liabilities-7.28M-4.42M2.15M25.3M9.57M
Cash From (used in) Discontinued Operations-----
Other Adjustments Net15.81M17.87M-347.6M11.13M2.1M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-27.84M-15.52M-6.51M-11.03M-10.96M
Acquisition Disposition of Subsidiaires-3.69M-82.56M13.06M--
Increase (Decrease) in Investments39.27M6.37M-50.23M-24.16M-
Other Cash Inflow (Outflow) from Investment Activities-20M-6.09M--3.57M-2.21M
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares171.02M1.25M209.23M-0.49M72.06M
Issuance (Repayment) of Debt Securities-121.25M--23M
Increase (Decrease) in Bank & Other Borrowings-----
Payment of Dividends & Other Cash Distributions-----
Other Cash from (used by) Financing Activities-5.47M-0.36M-1.36M-1.36M-
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash-----
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year170.02M145.72M-67.89M5.25M
Cash & Equivalents at Year End295.36M134.56M145.72M15.13M67.89M
All figures in USD. M: Millions of USD, B: Billions of USD.

While Evolent Health stock price history provides the price history of a stock, Evolent Health stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • Evolent Health has cash of $295.36M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Evolent Health stock price.
  • Cash Flow from operating activities: Evolent Health reported a negative operating cash flow of $-27.95M for 2017 and has seen an increase from the previous year. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-12.26M for EVH in last 2017 report.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Evolent Health earned $165.55M from financing activities, in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For Evolent Health Cash Flow

FCF margin

Annual Cash Flow Statements For Evolent Health Inc Peers

Amedisys cash flow, Civitas cash flow, CLOUDERA INC cash flow, LHC cash flow, Varonis cash flow